Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...

After consistently failing to meet investor expectations, Novo Nordisk touted a safety profile for CagriSema in line with the ...

While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

In advance of this week's CDC vaccine advisory meeting, HHS Secretary Robert F. Kennedy Jr. restacked the committee, claiming ...

Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s ...

Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign ...

Harliku is the only FDA-approved drug for alkaptonuria, a rare condition characterized by skin discoloration, arthritis and ...

Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug ...

California’s life sciences jobs led the nation last year, according to a new California Life Sciences (CLS) report. However, ...

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug ...